Skip to main content
. Author manuscript; available in PMC: 2021 May 3.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2020 Jan 14;13(1):e005902. doi: 10.1161/CIRCOUTCOMES.119.005902

Table 1.

Cardiac Rehabilitation Eligibility, Participation, and Utilization Among Medicare Fee-for-Service Beneficiaries Aged ≥65 Years Who Had a Primary Qualifying Event Type, 2016–2017

CR Eligible Participation Among Eligible Sessions Used Among Participants
N Rate/1000 N % aPR* (95% CI) Mean No. of Sessions (SD) ≥25 Sessions, % ≥36 Sessions
% aPR* (95% CI)
Total 366 103 13.0 89 327 24.4 NA 24.8 (12.0) 56.7 26.9 NA
 65–74 y 151 392 10.0 48 037 31.7 Referent 24.8 (12.0) 56.4 26.8 Referent
 75–84 y 134 699 15.6 33 436 24.8 0.93 (0.92–0.95) 25.2 (11.8) 57.9 27.6 1.08 (1.05–1.11)
 ≥ 85 y 80 012 18.0 7854 9.8 0.57 (0.56–0.59) 23.6 (12.4) 53.5 23.9 0.98 (0.93–1.03)
Sex
 Male 207 911 16.9 59 462 28.6 Referent 25.4 (11.8) 58.7 28.3 Referent
 Female 158 192 10.0 29 865 18.9 0.91 (0.90–0.93) 24.5 (12.2) 56.5 26.1 0.87 (0.85–0.90)
Race-ethnicity
 Non-Hispanic white 313 251 13.5 80 884 25.8 Referent 25.4 (11.9) 56.4 26.8 Referent
 Non-Hispanic black 22 865 11.0 3113 13.6 0.70 (0.67–0.72) 24.4 (12.5) 56.4 26.9 1.07 (1.00–1.14)
 Hispanic 16 182 11.1 2130 13.2 0.63 (0.61–0.66) 23.1 (12.9) 52.6 23.7 0.97 (0.89–1.06)
 Asian 6342 8.6 1033 16.3 0.80 (0.75–0.85) 24.3 (12.6) 55.6 26.3 1.06 (0.94–1.20)
 Other/unknown 7463 10.2 2167 29.0 0.96 (0.92–1.00) 25.4 (11.8) 58.7 27.5 1.00 (0.92–1.08)
Dual Medicare/Medicaid coverage
 No 324 167 12.8 86 449 26.7 Referent 25.0 (11.9) 57.2 27.2 Referent
 Yes 41 936 14.9 2878 6.9 0.40 (0.39–0.42) 19.6 (13.3) 40.7 16.8 0.65 (0.59–0.71)
Comorbidities
 0–2 54 874 4.6 20 619 37.6 Referent 25.3 (11.8) 57.5 29.0 Referent
 3–4 108 397 11.9 33 634 31.0 1.01 (0.99–1.03) 25.5 (11.7) 58.8 28.0 0.97 (0.94–1.00)
 5–6 133 522 24.8 27 066 20.3 0.87 (0.85–0.88) 24.4 (12.1) 55.6 25.5 0.89 (0.86–0.92)
 7–9 69 310 37.0 8008 11.6 0.65 (0.63–0.67) 22.5 (12.6) 49.6 21.3 0.76 (0.72–0.80)
Chronic kidney disease
 No 138 877 6.9 44 883 32.3 Referent 25.2 (11.8) 57.6 27.9 Referent
 Yes 227 226 28.0 44 444 19.6 0.86 (0.85–0.87) 24.4 (12.1) 55.8 25.8 0.94 (0.91–0.96)
PAC use§
 None 322 843 NA 84 076 26.1 Referent 24.9 (11.9) 53.7 25.5 Referent
 Any PAC use 43 260 NA 5251 12.1 0.61 (0.60–0.63) 25.1 (11.9) 58.3 26.7 1.03 (0.98–1.09)
  Home health only 25 034 NA 3743 15.0 0.71 (0.68–0.73) 25.1 (11.9) 58.7 26.8 1.03 (0.96–1.09)
  Any institutional PAC 18 226 NA 1508 8.3 0.46 (0.44–0.49) 25.1 (12.0) 57.4 26.5 1.04 (0.94–1.15)
Died >21 d of discharge
 No 317 377 NA 88 494 27.9 Referent 24.9 (11.9) 57.0 27.1 Referent
 Yes 48 726 NA 833 1.7 0.11 (0.11–0.12) 14.4 (11.5) 22.9 5.6 0.22 (0.17–0.30)

aPR indicates adjusted prevalence ratio; CR, cardiac rehabilitation; NA, not applicable; and PAC, post-acute care.

*

Adjusted, as appropriate, by age, sex, race-ethnicity, dual status, comorbidity count category, qualifying event type, and death status.

Count of the following: documented evidence of heart failure, atrial fibrillation, stroke/transient ischemic attack, endocrine or renal dysfunction, cancer, musculoskeletal or joint dysfunction, pulmonary dysfunction, cognitive or mental impairment, or ophthalmic dysfunction.

Covariates included in the adjusted model were modified by removing chronic kidney disease from one of the conditions included in the comorbidity count variable.

§

Covariates included in the adjusted model were modified by excluding qualifying event type because of collinearity with the PAC use variables.

Any use of a long-term care facility, skilled nursing facility, or inpatient rehabilitation facility with or without home health after the initial qualifying event occurred.

HHS Vulnerability Disclosure